Mead Johnson Nutriti
MJN
Delayed Nyse - 05/22 10:02:03 pm
89.02USD
+0.02%
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 20162017
Sales3 7433 614
EBITDA1 026940
Operating profit (EBIT)927829
Pre-Tax Profit (EBT)--
Net income545557
EPS ( $ )2,923,05
Dividend per Share ( $ )1,651,67
Yield2,33%1,87%
Announcement Date01/26/2017
12:30pm
-
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 20162017
Debt1 1851 288
Finance--
Operating income (EBITDA)1 026940
Leverage
(Debt/EBITDA)
1,15x1,37x
Capital Expenditure149142
Book Value Per Share (BVPS)-2,80 $-2,12 $
Cash Flow per Share3,72 $3,66 $
Announcement Date01/26/2017
12:30pm
-
Balance Sheet Analysis
Financial Ratios
Size 2017e 2018e
Capitalization 16 348 M$ -
Entreprise Value (EV) 17 636 M$ 17 727 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 29,2x 27,0x
Capitalization / Revenue 4,52x 4,37x
EV / Revenue 4,88x 4,74x
EV / EBITDA 18,8x 17,9x
Yield (DPS / Price) 1,87% 1,99%
Price to book (Price / BVPS) -42,0x -27,9x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 22,9% 23,9%
operating Leverage (Delta EBIT / Delta Sales) -3,07x 2,18x
Net Margin (Net Profit / Revenue) 15,4% 15,9%
ROA (Net Profit / Asset) 14,7% 15,8%
ROE (Net Profit / Equities) -103% -93,0%
Rate of Dividend 54,7% 53,7%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   3,93% 3,91%
Cash Flow / Sales 18,6% 19,0%
Capital Intensity (Assets / Sales) 1,05x 1,01x
Financial Leverage (Net Debt / EBITDA) 1,37x 1,39x
Price Earning Ratio
BNA & Dividende